Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Cibil Report
Get cibil report
My Account
Log In
Log into your account
Offers
Check out pre-approved offers now!
Languages
Chosen Language: English
Do Not Call
Do not call
En
Narayana Hrudayalaya Ltd. Share Price
N/A
1D
1M
3M
6M
1Y
5Y
Day's Range
Low
₹1,680.00
High
₹1,719.20
Price Summary
| Previous Close | ₹1,713.90 |
|---|---|
| Day's Range | ₹1,680.00 - ₹1,719.20 |
| Open | ₹1,714.50 |
| 52 Week Range | ₹1,589.00 - ₹2,093.30 |
| Volume | 34,747 |
| Market Cap | ₹0.04 |
| Previous Close | ₹1,715.00 |
|---|---|
| Day's Range | ₹1,704.00 - ₹1,718.00 |
| Open | ₹1,716.90 |
| 52 Week Range | ₹1,564.25 - ₹2,094.30 |
| Volume | 3,817 |
| Market Cap | ₹0.04 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 595.53 |
|---|---|
| Market Cap (₹ in Mn) | 0.04 |
| Dividend Yield(%) | 0.26 |
| Price/Earning (TTM) | 43.15 |
| TTM EPS (₹) | 39.94 |
| P/E Ratio | 40.73 |
| Book Value(₹) | 7.42 |
| PAT Margin (%) | 10.26 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 16.20 |
| Trade Value ( ₹ in Lacs) | 65.46 |
|---|---|
| Market Cap (₹ in Mn) | 0.04 |
| Dividend Yield(%) | 0.26 |
| Price/Earning (TTM) | 43.15 |
| TTM EPS (₹) | 39.94 |
| P/E Ratio | 40.73 |
| Book Value(₹) | 7.42 |
| PAT Margin (%) | 10.26 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 16.20 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 9431.41 | 54829.77 |
| Expenses | N/A | N/A |
| PBT | 1172.73 | 9355.38 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 873.71 | 7906.31 |
About Narayana Hrudayalaya Ltd.
| Founded | 2000 |
|---|---|
| Managing Director | Emmanuel Rupert |
| NSE Symbol | NH |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,21,803.09 | 1,759.40 | 1,583.70 - 1,583.70 |
| Divi's Laboratories Ltd. | 2,53,833.09 | 9,587.00 | 5,647.50 - 5,647.50 |
| Torrent Pharmaceuticals Ltd. | 1,73,461.06 | 4,577.50 | 3,532.60 - 3,532.60 |
| Lenskart Solutions Ltd. | 1,19,959.95 | 690.80 | 0.00 - 0.00 |
| Laurus Labs Ltd. | 1,18,055.52 | 2,174.80 | 917.95 - 917.95 |
| Apollo Hospitals Enterprise Ltd. | 1,17,040.71 | 8,170.00 | 6,696.50 - 6,696.50 |
| Zydus Lifesciences Ltd. | 1,16,907.45 | 1,173.60 | 835.50 - 835.50 |
| Dr. Reddy's Laboratories Ltd. | 1,11,463.21 | 1,347.20 | 1,101.00 - 1,101.00 |
| Cipla Ltd. | 1,09,870.40 | 1,360.05 | 1,165.70 - 1,165.70 |
| Mankind Pharma Ltd. | 1,02,583.88 | 2,471.55 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Oct
29
2026
Posted on Oct 29th 2026
Biocon informs about press release
Biocon has informed that it enclosed the press release titled ‘Biocon Named Among Science Magazine’s Best Employers in Global Biotech and Pharma for 2026’. The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
29
2026
Posted on Oct 29th 2026
Jagsonpal Pharma - Quaterly Results
A fair growth of 9.28% in the revenue at Rs. 813.75 millions was reported in the September 2026 quarter as compared to Rs. 744.65 millions during year-ago period.A meek growth of 0.13% was reported for the quarter ended September 2026 to Rs. 125.90 millions from Rs. 125.74 millions.Operating Profit reported a sharp decline to 189.97 millions from 194.61 millions in the corresponding previous quarter.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 813.75 | 744.65 | 9.28 | 1636.07 | 1500.77 | 9.02 | 2872.25 | 2687.16 | 6.89 |
| Other Income | 22.31 | 30.27 | -26.30 | 50.64 | 58.52 | -13.47 | 119.95 | 81.90 | 46.46 |
| PBIDT | 189.97 | 194.61 | -2.38 | 390.70 | 364.99 | 7.04 | 700.69 | 592.61 | 18.24 |
| Interest | 2.51 | 2.65 | -5.28 | 5.02 | 5.19 | -3.28 | 10.28 | 9.58 | 7.31 |
| PBDT | 185.11 | 191.96 | -3.57 | 383.33 | 359.80 | 6.54 | 669.62 | 779.90 | -14.14 |
| Depreciation | 16.83 | 23.86 | -29.46 | 38.25 | 47.39 | -19.29 | 94.44 | 81.31 | 16.15 |
| PBT | 168.28 | 168.10 | 0.11 | 345.08 | 312.41 | 10.46 | 575.18 | 698.59 | -17.67 |
| TAX | 42.38 | 42.36 | 0.05 | 87.29 | 78.72 | 10.89 | 144.36 | 144.98 | -0.43 |
| Deferred Tax | 2.47 | 4.29 | -42.42 | 5.60 | 8.94 | -37.36 | 12.49 | 9.26 | 34.88 |
| PAT | 125.90 | 125.74 | 0.13 | 257.79 | 233.69 | 10.31 | 430.82 | 553.61 | -22.18 |
| Equity | 133.27 | 133.27 | 0.00 | 133.27 | 133.27 | 0.00 | 133.93 | 132.80 | 0.85 |
| PBIDTM(%) | 23.35 | 26.13 | -10.67 | 23.88 | 24.32 | -1.81 | 24.40 | 22.05 | 10.62 |
Read More
Oct
29
2026
Posted on Oct 29th 2026
Zenith Health Care - Quaterly Results
The sales for the September 2026 quarter moved down to Rs. 20.11 millions as compared to Rs. 22.67 millions during the year-ago period.Net Profit for the quarter ended September 2026 dipped to Rs. 0.23 millions from Rs. 1.42 millions in the corresponding previous quarter.Operating profit for the quarter ended September 2026 decreased to 0.64 millions as compared to 2.85 millions of corresponding quarter ended September 2025.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 20.11 | 22.67 | -11.29 | 54.44 | 54.18 | 0.48 | 105.22 | 113.30 | -7.13 |
| Other Income | 1.24 | 1.09 | 13.76 | 1.93 | 2.75 | -29.82 | 4.14 | 4.31 | -3.94 |
| PBIDT | 0.64 | 2.85 | -77.54 | 3.07 | 3.23 | -4.95 | 2.83 | 5.23 | -45.89 |
| Interest | 0.01 | 0.01 | 0.00 | 0.02 | 0.05 | -60.00 | 0.09 | 0.12 | -25.00 |
| PBDT | 0.63 | 2.84 | -77.82 | 3.05 | 3.18 | -4.09 | 2.74 | 5.11 | -46.38 |
| Depreciation | 0.51 | 0.65 | -21.54 | 1.13 | 1.26 | -10.32 | 2.58 | 2.32 | 11.21 |
| PBT | 0.12 | 2.19 | -94.52 | 1.92 | 1.92 | 0.00 | 0.16 | 2.79 | -94.27 |
| TAX | -0.11 | 0.77 | -114.29 | 0.34 | 0.70 | -51.43 | 0.11 | 2.12 | -94.81 |
| Deferred Tax | -0.11 | 0.26 | -142.31 | -0.19 | 0.19 | -200.00 | -0.24 | 1.35 | -117.78 |
| PAT | 0.23 | 1.42 | -83.80 | 1.58 | 1.22 | 29.51 | 0.05 | 0.67 | -92.54 |
| Equity | 53.74 | 53.74 | 0.00 | 53.74 | 53.74 | 0.00 | 53.74 | 53.74 | 0.00 |
| PBIDTM(%) | 3.18 | 12.57 | -74.69 | 5.64 | 5.96 | -5.41 | 2.69 | 4.62 | -41.73 |
Read More
Oct
29
2026
Posted on Oct 29th 2026
Sudeep Pharma - Quaterly Results
The turnover is pegged at Rs. 1374.13 millions for the September 2026 quarter. The mentioned figure indicates a rise of about 56.36% as against Rs. 878.82 millions during the year-ago period.The company has announced a 42.35% increase in its profits to Rs . 423.38 millions for the quarter ended September 2026 compared to Rs. 297.42 millions in the corresponding quarter in the previous year.OP of the company witnessed a marginal growth to 621.21 millions from 437.06 millions in the same quarter last year.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 1374.13 | 878.82 | 56.36 | 2430.96 | 1680.56 | 44.65 | 3385.05 | 3567.32 | -5.11 |
| Other Income | 105.09 | 128.27 | -18.07 | 203.09 | 194.47 | 4.43 | 385.04 | 83.76 | 359.69 |
| PBIDT | 621.21 | 437.06 | 42.13 | 1111.16 | 807.18 | 37.66 | 1582.72 | 1403.33 | 12.78 |
| Interest | 22.96 | 20.29 | 13.16 | 40.56 | 34.66 | 17.02 | 60.66 | 48.10 | 26.11 |
| PBDT | 598.25 | 416.77 | 43.54 | 1070.60 | 772.52 | 38.59 | 1522.06 | 1355.23 | 12.31 |
| Depreciation | 30.54 | 17.73 | 72.25 | 48.80 | 35.21 | 38.60 | 71.10 | 61.17 | 16.23 |
| PBT | 567.71 | 399.04 | 42.27 | 1021.80 | 737.31 | 38.58 | 1450.96 | 1294.06 | 12.12 |
| TAX | 144.33 | 101.62 | 42.03 | 260.12 | 187.84 | 38.48 | 375.16 | 336.59 | 11.46 |
| Deferred Tax | 14.23 | 4.86 | 192.80 | 31.46 | 9.11 | 245.33 | 31.93 | 5.26 | 507.03 |
| PAT | 423.38 | 297.42 | 42.35 | 761.68 | 549.47 | 38.62 | 1075.80 | 957.47 | 12.36 |
| Equity | 112.95 | 97.23 | 16.17 | 112.95 | 97.23 | 16.17 | 112.95 | 97.23 | 16.17 |
| PBIDTM(%) | 45.21 | 49.73 | -9.10 | 45.71 | 48.03 | -4.83 | 46.76 | 39.34 | 18.86 |
Read More
Oct
29
2026
Posted on Oct 29th 2026
Zenotech Labs. - Quaterly Results
The sales slipped to Rs. 71.48 millions, down -36.38% for the September 2026 quarter as against Rs. 112.36 millions during the year-ago period.The Net Loss for the quarter ended September 2026 is Rs. -25.72 millions as compared to Net Loss of Rs. -8.37 millions of corresponding quarter ended September 2025Operating profit Margin for the quarter ended September 2026 slipped to -16.05% as compared to 29.90% of corresponding quarter ended September 2025
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 71.48 | 112.36 | -36.38 | 177.60 | 208.79 | -14.94 | 436.14 | 430.47 | 1.32 |
| Other Income | 4.24 | 7.00 | -39.43 | 8.60 | 12.88 | -33.23 | 23.09 | 15.49 | 49.06 |
| PBIDT | -16.05 | 29.90 | -153.68 | -3.03 | 60.40 | -105.02 | 114.98 | 157.29 | -26.90 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | -16.05 | 30.40 | -152.80 | -3.03 | 60.90 | -104.98 | 113.03 | 176.52 | -35.97 |
| Depreciation | 18.15 | 17.82 | 1.85 | 37.17 | 35.56 | 4.53 | 71.13 | 69.60 | 2.20 |
| PBT | -34.20 | 12.58 | -371.86 | -40.20 | 25.34 | -258.64 | 41.90 | 106.92 | -60.81 |
| TAX | -8.48 | 20.95 | -140.48 | -9.93 | 23.82 | -141.69 | 52.61 | 50.79 | 3.58 |
| Deferred Tax | -8.48 | 42.22 | -120.09 | -9.93 | 42.87 | -123.16 | 47.72 | 25.86 | 84.53 |
| PAT | -25.72 | -8.37 | 207.29 | -30.27 | 1.52 | -2091.45 | -10.71 | 56.13 | -119.08 |
| Equity | 610.31 | 610.31 | 0.00 | 610.31 | 610.31 | 0.00 | 610.31 | 610.31 | 0.00 |
| PBIDTM(%) | -22.45 | 26.61 | -184.38 | -1.71 | 28.93 | -105.90 | 26.36 | 36.54 | -27.85 |
Read More
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Narayana Hrudayalaya Ltd. is ₹1,713.90 as of 2026-10-29.
The market capitalisation of Narayana Hrudayalaya Ltd. is ₹35,213.41 as of 2026-10-28.
The 1-year return of Narayana Hrudayalaya Ltd. is -62.10% as of 2026-10-29.
The P/E ratio of Narayana Hrudayalaya Ltd. is 40.73 as of 2026-10-29.
The 52-week high and low of Narayana Hrudayalaya Ltd. are ₹2,093.30 and ₹1,589.00, respectively, as of 2026-10-29.
View More
People Also Ask
Narayana Hrudayalaya Ltd. establishes partnerships by collaborating with regional governments to operate specialised public-private healthcare facilities. The hospital chain also works closely with medical technology firms to implement advanced, cost-effective surgical equipment across its network.
Narayana Hrudayalaya Ltd. provides extensive multi-specialty healthcare facilities, operating a network of over 40 hospitals and primary care clinics. The enterprise is globally ren
View More
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
Home
Shopping
Loan Offers
My Accounts
Explore
